Topical application of EGF for the therapy of persisting corneal erosion under cetuximab treatment;Topische EGF-Applikation bei therapierefraktärer Erosio corneae unter Cetuximab-Behandlung

Ophthalmologe

Volumn 105, Issue 3, 2008, Pages 269-273

  Forster C G ^a   Cursiefen, C ^a   Kruse, F E ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cetuximab; Corneal wound healing; Epidermal growth factor; Epidermal growth factor receptor

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; CORNEA DISEASE; CORNEA EPITHELIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; MIDDLE AGED; WOUND HEALING;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CORNEAL DISEASES; EPIDERMAL GROWTH FACTOR; EPITHELIUM, CORNEAL; FEMALE; HUMANS; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; WOUND HEALING;

EID: 41149113837     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-007-1527-8     Document Type: Article

References (6)

1. Cunningham D, Humblet Y, Siena S et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351: 337-345
2. Liu Z, Carvajal M, Carraway CA et al. (2001) Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2 and ErbB3 in human ocular surface epithelia. Cornea 20: 81-85
3. Nahamura Y, Sotozono C, Kinoshita S (2001) The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis. Exp Eye Res 72: 511-517
4. Vallbohmer D, Lenz HJ (2005) Epidermal growth factor receptor as a target for chemotherapy. Clin Colorectal Cancer (Suppl 1) 5: S19-S27
5. Vicenzi B, Santini D, Rabitti C et al. (2006) Cetuximab and irinotecan as third-line therapy in andvanced colorectal cancer patients: a single centre phase II trial. Br J Cancer 94: 792-797
6. Yang H, Mergler S, Sun X et al. (2005) TRPC4 knockdown suppresses epidermal growth factor-induced store-operated channel activation and growth in human corneal epithelial cells. J Biol Chem 280: 32230-32237